Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 28,935 | -1,917 | 11,992 | 13,594 | 12,606 |
Gross Profit | 28,935 | -1,917 | 11,992 | 13,594 | 12,606 |
Operating Expenses | 142,938 | 137,975 | 143,099 | 145,928 | 124,564 |
Operating Income | -114,003 | -139,892 | -131,107 | -132,334 | -111,958 |
Other Income | 6,567 | 7,731 | 8,883 | 8,653 | 8,832 |
Pre-tax Income | -107,436 | -132,161 | -122,224 | -123,681 | -103,126 |
Net Income Continuous | -107,436 | -132,161 | -122,224 | -123,681 | -103,126 |
Net Income | $-107,436 | $-132,161 | $-122,224 | $-123,681 | $-103,126 |
EPS Basic Total Ops | -1.12 | -1.47 | -1.38 | -1.40 | -1.17 |
EPS Basic Continuous Ops | -1.13 | -1.46 | -1.38 | -1.40 | -1.17 |
EPS Diluted Total Ops | -1.12 | -1.47 | -1.38 | -1.40 | -1.17 |
EPS Diluted Continuous Ops | -1.13 | -1.46 | -1.38 | -1.40 | -1.17 |
EPS Diluted Before Non-Recurring Items | -1.06 | -1.46 | -1.38 | -1.40 | -1.17 |
EBITDA(a) | $-111,491 | $-137,426 | $-128,817 | $-130,164 | $-109,908 |